BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roy I, Krishnan S, Kabashin AV, Zavestovskaya IN, Prasad PN. Transforming Nuclear Medicine with Nanoradiopharmaceuticals. ACS Nano 2022. [PMID: 35294165 DOI: 10.1021/acsnano.1c10550] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lindsley CW, Müller CE, Bongarzone S. Diagnostic and Therapeutic Radiopharmaceuticals. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00173] [Reference Citation Analysis]
2 Lindsley CW, Müller CE, Bongarzone S. Diagnostic and Therapeutic Radiopharmaceuticals. J Med Chem . [DOI: 10.1021/acs.jmedchem.2c01403] [Reference Citation Analysis]
3 Caers J, Duray E, Vrancken L, Marcion G, Bocuzzi V, De Veirman K, Krasniqi A, Lejeune M, Withofs N, Devoogdt N, Dumoulin M, Karlström AE, D’huyvetter M. Radiotheranostic Agents in Hematological Malignancies. Front Immunol 2022;13:911080. [DOI: 10.3389/fimmu.2022.911080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xu Y, Nie Z, Ni N, Zhang X, Yuan J, Gao Y, Gong Y, Liu S, Wu M, Sun X. Shield-activated two-way imaging nanomaterials for enhanced cancer theranostics. Biomater Sci 2022. [DOI: 10.1039/d2bm01317g] [Reference Citation Analysis]